Unknown PHASE4 INTERVENTIONAL 2-arm NCT05089942

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021 in Healthy and Diabetic Patients

Sponsor: Zhejiang Provincial People's Hospital

Interventions Placebo Recombinant Human Insulin Patch ZJSRM2021

Updated 5 times since 2021 Last updated: Nov 11, 2021 Started: Dec 31, 2021 Primary completion: Dec 31, 2021 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Type2 Diabetes and type1diabetes, this trial is ongoing. The trial is conducted by Zhejiang Provincial People's Hospital and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Dec 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Dec 2021 — Dec 2023 [monthly]

Not Yet Recruiting PHASE4
Nov 2021 — Dec 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhejiang Provincial People's Hospital

Data source: Zhejiang Provincial People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China